Your browser doesn't support javascript.
loading
Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses.
Guthmiller, Jenna J; Lan, Linda Yu-Ling; Fernández-Quintero, Monica L; Han, Julianna; Utset, Henry A; Bitar, Dalia J; Hamel, Natalie J; Stovicek, Olivia; Li, Lei; Tepora, Micah; Henry, Carole; Neu, Karlynn E; Dugan, Haley L; Borowska, Marta T; Chen, Yao-Qing; Liu, Sean T H; Stamper, Christopher T; Zheng, Nai-Ying; Huang, Min; Palm, Anna-Karin E; García-Sastre, Adolfo; Nachbagauer, Raffael; Palese, Peter; Coughlan, Lynda; Krammer, Florian; Ward, Andrew B; Liedl, Klaus R; Wilson, Patrick C.
Afiliação
  • Guthmiller JJ; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
  • Lan LY; Committee on Immunology, University of Chicago, Chicago, IL 60637, USA.
  • Fernández-Quintero ML; Center for Molecular Biosciences Innsbruck, Institute of General, Inorganic and Theoretical Chemistry, University of Innsbruck, 6020 Innsbruck, Austria.
  • Han J; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Utset HA; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
  • Bitar DJ; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
  • Hamel NJ; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
  • Stovicek O; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
  • Li L; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
  • Tepora M; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
  • Henry C; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
  • Neu KE; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA; Committee on Immunology, University of Chicago, Chicago, IL 60637, USA.
  • Dugan HL; Committee on Immunology, University of Chicago, Chicago, IL 60637, USA.
  • Borowska MT; Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 60637, USA.
  • Chen YQ; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
  • Liu STH; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Stamper CT; Committee on Immunology, University of Chicago, Chicago, IL 60637, USA.
  • Zheng NY; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
  • Huang M; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
  • Palm AE; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
  • García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount S
  • Nachbagauer R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Palese P; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Coughlan L; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Microbiology and Immunology and Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Liedl KR; Center for Molecular Biosciences Innsbruck, Institute of General, Inorganic and Theoretical Chemistry, University of Innsbruck, 6020 Innsbruck, Austria.
  • Wilson PC; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA; Committee on Immunology, University of Chicago, Chicago, IL 60637, USA. Electronic address: wilsonp@uchicago.edu.
Immunity ; 53(6): 1230-1244.e5, 2020 12 15.
Article em En | MEDLINE | ID: mdl-33096040
Polyreactivity is the ability of a single antibody to bind to multiple molecularly distinct antigens and is a common feature of antibodies induced upon pathogen exposure. However, little is known about the role of polyreactivity during anti-influenza virus antibody responses. By analyzing more than 500 monoclonal antibodies (mAbs) derived from B cells induced by numerous influenza virus vaccines and infections, we found mAbs targeting conserved neutralizing influenza virus hemagglutinin epitopes were polyreactive. Polyreactive mAbs were preferentially induced by novel viral exposures due to their broad viral binding breadth. Polyreactivity augmented mAb viral binding strength by increasing antibody flexibility, allowing for adaption to imperfectly conserved epitopes. Lastly, we found affinity-matured polyreactive B cells were typically derived from germline polyreactive B cells that were preferentially selected to participate in B cell responses over time. Together, our data reveal that polyreactivity is a beneficial feature of antibodies targeting conserved epitopes.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Orthomyxoviridae / Linfócitos B / Anticorpos Amplamente Neutralizantes Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Orthomyxoviridae / Linfócitos B / Anticorpos Amplamente Neutralizantes Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article